Pacific Biosciences Of California PACB
NASDAQ PACB
$1.30 +0.03 (+2.36%)
At close: Aug 20, 2026 · 11:18 AM UTC

Pacific Biosciences Of California (PACB) Interest & Investment Income (2012 - 2013)

Pacific Biosciences Of California (PACB) posted quarterly Interest & Investment Income of -$19000.0 for Q1 2013, down 124.36% year-over-year from $78000.0 in Q1 2012, and down 124.36% quarter-over-quarter from $78000.0 in Q1 2012.

Pacific Biosciences Of California (PACB) Interest & Investment Income (2012 - 2013) Analysis & Trends

Pacific Biosciences Of California's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$19000.0 for Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 52.00 Mn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn -
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 30.00 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 73.23 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 Pacific Biosciences Of California 400.74 Mn 163.87 Mn 12.64 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2013 -19,000.00
Mar 31, 2012 78,000.00